Presynaptic TRPV1 vanilloid receptor function is age- but not CB1 cannabinoid receptor-dependent in the rodent forebrain

Brain Research Bulletin

Volumn 97, Issue , 2013, Pages 126-135

  Köles, László ^a   Garção, Pedro ^b   Zádori, Zoltán S ^a   Ferreira, Samira G ^b   Pinheiro, Bárbara S ^b   da Silva Santos, Carla S ^b   Ledent, Catherine ^c   Köfalvi, Attila ^b,d  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^d UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

CB1 cannabinoid receptor; Dopamine; Glutamate; Serotonin; Striatum; TRPV1 vanilloid receptor

Indexed keywords

CANNABINOID 1 RECEPTOR; VANILLOID RECEPTOR 1; 4 (2 HYDROXYETHYL) 1 PIPERAZINEETHANESULFONIC ACID; 4 AMINOBUTYRIC ACID; 4 AMINOPYRIDINE; ADENOSINE TRIPHOSPHATE MAGNESIUM; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; BENZYLSULFONYL FLUORIDE; BICINCHONINIC ACID; BOVINE SERUM ALBUMIN; CAPSAICIN; DIMETHYL SULFOXIDE; DITHIOTHREITOL; DODECYL SULFATE SODIUM; DOPAMINE; EDETIC ACID; EGTAZIC ACID; GLUTAMIC ACID; NITRIC OXIDE; POLYVINYLIDENE DIFLUORIDE; POLYVINYLIDENE FLUORIDE; RESINIFERATOXIN; SEROTONIN; TROMETAMOL; TRPV1 RECEPTOR; VANILLOID RECEPTOR;

AGE DISTRIBUTION; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC ACTIVITY; FEMALE; FOREBRAIN; GLUTAMATERGIC ACTIVITY; MALE; MEMBRANE CURRENT; MEMBRANE POTENTIAL; NEOCORTEX; NERVOUS SYSTEM ELECTROPHYSIOLOGY; NERVOUS SYSTEM PARAMETERS; NEUROCHEMISTRY; NONHUMAN; PATCH CLAMP; PRESYNAPTIC POTENTIAL; PRIORITY JOURNAL; RAT; SEROTONINERGIC SYSTEM; Γ-AMINOBUTYRIC ACID; 3RS; 4-AP; 7-, 14-, 29- AND 60-DAY-OLD; 7D, 14D, 29D, 60D; ACEA; ACSF; AMERICAN RADIOLABELED CHEMICALS; ANIMAL; ANIMAL RESEARCH: REPORTING IN VIVO EXPERIMENTS; ARACHIDONYL-2′-CHLOROETHYLAMIDE; ARC; AREA UNDER THE CURVE; AREA-UNDER-THE-CURVE; ARRIVE; BCA; BSA; CANNABINOID RECEPTOR TYPE 1; CB(1) CANNABINOID RECEPTOR; CB(1)R; CEREBROSPINAL FLUID SUBSTITUTE; CORPUS STRIATUM; DISINTEGRATION PER MINUTE; DPM; DRUG EFFECT; ECF; ENHANCED CHEMI-FLUORESCENCE; ETHYLENE GLYCOL-BIS(2-AMINOETHYLETHER)-N,N,N′,N′-TETRAACETIC ACID; EXCITATORY POSTSYNAPTIC POTENTIAL; FEDERATION FOR LABORATORY ANIMAL SCIENCE ASSOCIATIONS; FELASA; FR%; FRACTIONAL RELEASE %; GENETICS; GROWTH, DEVELOPMENT AND AGING; IN VITRO STUDY; KHR; KNOCK OUT; KNOCKOUT MOUSE; KO; KREBS-HEPES-RINGER; LIGTP; LITHIUM GUANOZINE TRIPHOSPHATE; MAO B; METABOLISM; MGATP; MOUSE; N-(2-HYDROXYETHYL)PIPERAZINE-N′-(2-ETHANESULFONIC ACID); N-ARACHIDONYL DOPAMINE; NADA; NO; PHYSIOLOGY; PMSF; REPLACEMENT, REDUCTION, REFINEMENT; RTX; SCANNING ELECTRON MICROSCOPY; SCINTISCANNING; SDS; SECRETION (PROCESS); SEPSCS; SPONTANEOUS EXCITATORY POSTSYNAPTIC CURRENTS; STANDARD ERROR OF THE MEAN; SYNAPTOSOME; TBS-T; TRANSIENT RELEASE POTENTIAL RECEPTOR VANILLOID TYPE 4; TRIS-BUFFERED SALINE WITH TWEEN 20; TRPV(1) VANILLOID RECEPTOR; TRPV(1)R AND TRPV(4)R; WILD-TYPE; WISTAR RAT; WT; DRUG EFFECTS;

Γ-AMINOBUTYRIC ACID; 3RS; 4-AMINOPYRIDINE; 4-AP; 7-, 14-, 29- AND 60-DAY-OLD; 7D, 14D, 29D, 60D; ACEA; ACSF; AMERICAN RADIOLABELED CHEMICALS; ANIMAL RESEARCH: REPORTING IN VIVO EXPERIMENTS; ARACHIDONYL-2′-CHLOROETHYLAMIDE; ARC; AREA-UNDER-THE-CURVE; ARRIVE; ARTIFICIAL CEREBROSPINAL FLUID; AUC; BCA; BICINCHONINIC ACID; BOVINE SERUM ALBUMIN; BSA; CANNABINOID RECEPTOR TYPE 1; CB(1) CANNABINOID RECEPTOR; CB(1)R; DIMETHYL SULFOXIDE; DISINTEGRATION PER MINUTE; DITHIOTHREITOL; DMSO; DOPAMINE; DPM; DTT; ECF; EDTA; EGTA; ENHANCED CHEMI-FLUORESCENCE; ETHYLENE GLYCOL-BIS(2-AMINOETHYLETHER)-N,N,N′,N′-TETRAACETIC ACID; ETHYLENEDIAMINETETRAACETIC ACID; FEDERATION FOR LABORATORY ANIMAL SCIENCE ASSOCIATIONS; FELASA; FR%; FRACTIONAL RELEASE %; GABA; GLUTAMATE; HEPES; KHR; KNOCKOUT; KO; KREBS-HEPES-RINGER; LIGTP; LITHIUM GUANOZINE TRIPHOSPHATE; MAGNESIUM ADENOSINE TRIPHOSPHATE; MAO B; MGATP; MONOAMINE OXIDASE B; N-(2-HYDROXYETHYL)PIPERAZINE-N′-(2-ETHANESULFONIC ACID); N-ARACHIDONYL DOPAMINE; NADA; NITRIC OXIDE; NO; PHENYLMETHANESULFONYL FLUORIDE; PMSF; POLYVINYLIDENE DIFLUORIDE; PVDF; REPLACEMENT, REDUCTION, REFINEMENT; RESINIFERATOXIN; RTX; SDS; SEM; SEPSCS; SEROTONIN; SODIUM DODECYL SULFATE; SPONTANEOUS EXCITATORY POSTSYNAPTIC CURRENTS; STANDARD ERROR OF THE MEAN; STRIATUM; TBS-T; TRANSIENT RELEASE POTENTIAL RECEPTOR VANILLOID TYPE 4; TRIS; TRIS(HYDROXYMETHYL)AMINOMETHANE; TRIS-BUFFERED SALINE WITH TWEEN 20; TRPV(1) VANILLOID RECEPTOR; TRPV(1)R AND TRPV(4)R; WILD-TYPE; WT;

ANIMALS; CAPSAICIN; CORPUS STRIATUM; DOPAMINE; EXCITATORY POSTSYNAPTIC POTENTIALS; FEMALE; GLUTAMIC ACID; MALE; MICE; MICE, KNOCKOUT; PRESYNAPTIC TERMINALS; RATS; RATS, WISTAR; RECEPTOR, CANNABINOID, CB1; SEROTONIN; TRPV CATION CHANNELS; IN VITRO TECHNIQUES;

EID: 84880816335     PISSN: 03619230     EISSN: 18732747     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2013.06.007     Document Type: Article

References (70)

1. Al-Hayani A., Wease K.N., Ross R.A., Pertwee R.G., Davies S.N. The endogenous cannabinoid anandamide activates vanilloid receptors in the rat hippocampal slice. Neuropharmacology 2001, 41:1000-1005.
2. 1 desensitisation and endogenous vanilloid involvement in the enhanced analgesia induced by capsaicin in inflamed tissues. Brain Research Bulletin 2005, 67:476-481.
3. 3H]serotonin release from the rat hippocampus. Neurochemistry International 2008, 52:95-102.
4. 1 vanilloid receptor knockout mice. Neurochemistry International 2008, 52:89-94.
5. Berghuis P., Rajnicek A.M., Morozov Y.M., Ross R.A., Mulder J., Urbán G.M., Monory K., Marsicano G., Matteoli M., Canty A., Irving A.J., Katona I., Yanagawa Y., Rakic P., Lutz B., Mackie K., Harkany T. Hardwiring the brain: endocannabinoids shape neuronal connectivity. Science 2007, 316:1212-1216.
6. 1 receptor involvement. Neuroscience 1987, 20:757-771.
7. Cannizzaro C., D'Amico M., Preziosi P., Martire M. Presynaptic effects of anandamide and WIN55,212-2 on glutamatergic nerve endings isolated from rat hippocampus. Neurochemistry International 2006, 48:159-165.
8. 1) on the modulation of panic-like responses in rats. Neuropsychopharmacology 2012, 37:478-486.
9. Caterina M.J., Schumacher M.A., Tominaga M., Rosen T.A., Levine J.D., Julius D. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 1997, 389:816-824.
10. Chahl L.A. TRP channels and psychiatric disorders. Advances in Experimental Medicine and Biology 2011, 704:987-1009.
11. Cristino L., De Petrocellis L., Pryce G., Baker D., Guglielmotti V., Di Marzo V. Immunohistochemical localization of cannabinoid type 1 and vanilloid transient receptor potential vanilloid type 1 receptors in the mouse brain. Neuroscience 2006, 139:1405-1415.
12. 3H]GABA from synaptosomes isolated from the rat hippocampus. Neurochemical Research 2004, 29:1553-1561.
13. Descarries L., Bérubé-Carrière N., Riad M., Bo G.D., Mendez J.A., Trudeau L.E. Glutamate in dopamine neurons: synaptic versus diffuse transmission. Brain Research Reviews 2008, 58:290-302.
14. Di Marzo V., De Petrocellis L. Endocannabinoids as regulators of transient receptor potential (TRP) channels: a further opportunity to develop new endocannabinoid-based therapeutic drugs. Current Medicinal Chemistry 2010, 17:1430-1449.
15. Edwards F.A., Konnerth A., Sakmann B., Takahashi T. A thin slice preparation for patch clamp recordings from neurones of the mammalian central nervous system. Pflugers Archiv 1989, 414:600-612.
16. Ferreira S.G., Lomaglio T., Avelino A., Cruz F., Oliveira C.R., Cunha R.A., Köfalvi A. N-acyldopamines control striatal input terminals via novel ligand-gated cation channels. Neuropharmacology 2009, 56:676-683.
17. 1 cannabinoid receptors control frontocortical serotonin and glutamate release - species differences. Neurochemistry International 2012, 61:219-226.
18. 2A receptors in the control of dopamine release in the rat striatum. British Journal of Pharmacology 2013, In press.
19. 1 channels mediate long-term depression at synapses on hippocampal interneurons. Neuron 2008, 57:746-759.
20. 1 triggers cell type-specific long-term depression in the nucleus accumbens. Nature Neuroscience 2010, 13:1519-1525.
21. Hájos N., Freund T.F. Distinct cannabinoid sensitive receptors regulate hippocampal excitation and inhibition. Chemistry and Physics of Lipids 2002, 121:73-82.
22. Häring M., Marsicano G., Lutz B., Monory K. Identification of the cannabinoid receptor type 1 in serotonergic cells of raphe nuclei in mice. Neuroscience 2007, 146:1212-1219.
23. 1 receptor ligands against nicotine-induced depression-like behaviors. BMC Pharmacology 2011, 11:6.
24. 1 receptors. Proceedings of the National Academy of Sciences of the United States of America 2002, 99:8400-8405.
25. 1-induced long-term depression of hippocampal interneurons. Neuroscience Letters 2012, 510:82-87.
26. Jo K.D., Lee K.S., Lee W.T., Hur M.S., Kim H.J. Expression of transient receptor potential channels in the ependymal cells of the developing rat brain. Anatomy & Cell Biology 2013, 46:68-78.
27. Katona I., Freund T.F. Multiple functions of endocannabinoid signaling in the brain. Annual Review of Neuroscience 2012, 35:529-558.
28. 1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons. Journal of Neuroscience 1999, 19:4544-4558.
29. Kilkenny C., Browne W., Cuthill I.C., Emerson M., Altman D.G. Animal research: reporting in vivo experiments: the ARRIVE guidelines. British Journal of Pharmacology 2010, 160:1577-1579.
30. Köfalvi A. Alternative Interacting Sites and Novel Receptors for Cannabinoid Ligands. Cannabinoids and the Brain 2008, 131-160. Springer, USA. A. Köfalvi (Ed.).
31. 1 vanilloid receptors in rat hippocampal nerve terminals. Neuroscience Letters 2006, 403:151-156.
32. 2+ levels and transmitter release in the hippocampus. British Journal of Pharmacology 2007, 151:551-563.
33. Köfalvi A., Rodrigues R.J., Ledent C., Mackie K., Vizi E.S., Cunha R.A., Sperlágh B. Involvement of cannabinoid receptors in the regulation of neurotransmitter release in the rodent striatum: a combined immunochemical and pharmacological analysis. Journal of Neuroscience 2005, 25:2874-2884.
34. 1 receptor knockout mice. Science 1999, 283:401-404.
35. 1 channel on synaptic plasticity and spatial memory. Biological Psychiatry 2008, 64:286-292.
36. Maccarrone M., Rossi S., Bari M., De Chiara V., Fezza F., Musella A., Gasperi V., Prosperetti C., Bernardi G., Finazzi-Agrò A., Cravatt B.F., Centonze D. Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum. Nature Neuroscience 2008, 11:152-159.
37. Mahmud A., Santha P., Paule C.C., Nagy I. Cannabinoid 1 receptor activation inhibits transient receptor potential vanilloid type 1 receptor-mediated cationic influx into rat cultured primary sensory neurons. Neuroscience 2009, 162:1202-1211.
38. 1 channels control synaptic plasticity in the developing superior colliculus. Journal of Physiology 2009, 587:2521-2535.
39. Marinelli S., Di Marzo V., Florenzano F., Fezza F., Viscomi M.T., van der Stelt M., Bernardi G., Molinari M., Maccarrone M., Mercuri N.B. N-arachidonoyl-dopamine tunes synaptic transmission onto dopaminergic neurons by activating both cannabinoid and vanilloid receptors. Neuropsychopharmacology 2007, 32:298-308.
40. Marinelli S., Di Marzo V., Berretta N., Matias I., Maccarrone M., Bernardi G., Mercuri N.B. Presynaptic facilitation of glutamatergic synapses to dopaminergic neurons of the rat substantia nigra by endogenous stimulation of vanilloid receptors. Journal of Neuroscience 2003, 23:3136-3144.
41. 1 in the VTA excites dopaminergic neurons and increases chemical- and noxious-induced dopamine release in the nucleus accumbens. Neuropsychopharmacology 2005, 30:864-870.
42. Marinelli S., Vaughan C.W., Christie M.J., Connor M. Capsaicin activation of glutamatergic synaptic transmission in the rat locus coeruleus in vitro. Journal of Physiology 2002, 543:531-540.
43. Marsch R., Foeller E., Rammes G., Bunck M., Kössl M., Holsboer F., Zieglgänsberger W., Landgraf R., Lutz B., Wotjak C.T. Reduced anxiety, conditioned fear, and hippocampal long-term potentiation in transient receptor potential vanilloid type 1 receptor-deficient mice. Journal of Neuroscience 2007, 27:832-839.
44. 1 and synaptic transmission. Current Pharmaceutical Biotechnology 2011, 12:95-101.
45. McGrath J.C., Drummond G.B., McLachlan E.M., Kilkenny C., Wainwright C.L. Guidelines for reporting experiments involving animals: the ARRIVE guidelines. British Journal of Pharmacology 2010, 160:1573-1576.
46. 1), and VR1-like immunoreactivity, in the central nervous system of the rat and human. Proceedings of the National Academy of Sciences of the United States of America 2000, 97:3655-3660.
47. Micale V., Di Marzo V., Sulcova A., Wotjak C.T., Drago F. Endocannabinoid system and mood disorders: priming a target for new therapies. Pharmacology & Therapeutics 2013, 138:18-37.
48. Moreira F.A., Aguiar D.C., Terzian A.L., Guimarães F.S., Wotjak C.T. Cannabinoid type 1 receptors and transient receptor potential vanilloid type 1 channels in fear and anxiety-two sides of one coin. Neuroscience 2012, 204:186-192.
49. Moreira F.A., Wotjak C.T. Cannabinoids and anxiety. Current Topics in Behavioral Neurosciences 2010, 2:429-450.
50. 1 channels regulate cortical excitability in humans. Journal of Neuroscience 2012, 32:873-879.
51. Mulder J., Zilberter M., Pasquaré S.J., Alpár A., Schulte G., Ferreira S.G., Köfalvi A., Martín-Moreno A.M., Keimpema E., Tanila H., Watanabe M., Mackie K., Hortobágyi T., de Ceballos M.L., Harkany T. Molecular reorganization of endocannabinoid signalling in Alzheimer's disease. Brain 2011, 134:1041-1060.
52. 1 channels facilitate glutamate transmission in the striatum. Molecular and Cellular Neuroscience 2009, 40:89-97.
53. 1 ion channel. Cannabinoids and the Brain 2008, 101-131. Springer, USA. A. Köfalvi (Ed.).
54. 1 receptors. Naunyn-Schmiedeberg's Archives of Pharmacology 2000, 361:19-24.
55. 1 cannabinoid receptor stimulation modulates transient receptor potential vanilloid receptor 1 activities in calcium influx and substance P Release in cultured rat dorsal root ganglion cells. Journal of Pharmacological Sciences 2005, 97:377-385.
56. Raiteri L., Raiteri M. Synaptosomes still viable after 25 years of superfusion. Neurochemical Research 2000, 25:1265-1274.
57. 2A receptors in the hippocampus and striatum of the rat. Neuroscience 2005, 132:893-903.
58. Riebe C.J., Pamplona F., Kamprath K., Wotjak C.T. Fear relief-toward a new conceptual frame work and what endocannabinoids gotta do with it. Neuroscience 2012, 204:159-185.
59. 1 (VR-1) protein distribution. Brain Research 2004, 995:176-183.
60. Sasamura T., Sasaki M., Tohda C., Kuraishi Y. Existence of capsaicin-sensitive glutamatergic terminals in rat hypothalamus. Neuroreport 1998, 9:2045-2048.
61. Szolcsanyi J., Szallasi A., Szallasi Z., Joo F., Blumberg P.M. Resiniferatoxin: an ultrapotent selective modulator of capsaicin-sensitive primary afferent neurons. Journal of Pharmacology and Experimental Therapeutics 1990, 255:923-928.
62. 1) in the adult rat brain. Brain Research. Molecular Brain Research 2005, 135:162-168.
63. Vay L., Gu C., McNaughton P.A. The thermo-TRP ion channel family: properties and therapeutic implications. British Journal of Pharmacology 2012, 165:787-801.
64. Walker J.M., Krey J.F., Chu C.J., Huang S.M. Endocannabinoids and related fatty acid derivatives in pain modulation. Chemistry and Physics of Lipids 2002, 121:159-172.
65. Whittaker V.P., Michaelson I.A., Kirkland R.J.A. The separation of synaptic vesicles from nerve-ending particles ('synaptosomes'). Biochemical Journal 1964, 90:293-303.
66. A receptor-mediated synaptic currents in a subpopulation of rat striatal neurons. Neuropharmacology 2004, 46:994-1007.
67. Wu Z.Z., Chen S.R., Pan H.L. Transient receptor potential vanilloid type 1 activation down-regulates voltage-gated calcium channels through calcium-dependent calcineurin in sensory neurons. Journal of Biological Chemistry 2005, 280:18142-18151.
68. Yang Y., Yang H., Wang Z., Varadaraj K., Kumari S.S., Mergler S., Okada Y., Saika S., Kingsley P.J., Marnett L.J., Reinach P.S. Cannabinoid receptor 1 suppresses transient receptor potential vanilloid 1-induced inflammatory responses to corneal injury. Cellular Signalling 2013, 25:501-511.
69. Zavitsanou K., Dalton V.S., Wang H., Newson P., Chahl L.A. Receptor changes in brain tissue of rats treated as neonates with capsaicin. Journal of Chemical Neuroanatomy 2010, 39:248-255.
70. 1. PLoS One 2011, 6:e16116.